2012influvac product presentation
TRANSCRIPT
-
7/31/2019 2012Influvac Product Presentation
1/22
PROTECT YOUR WORLD
and you!
-
7/31/2019 2012Influvac Product Presentation
2/22
Are you influvaccinated?
your family
your teammate
your employees
your organization
YOUR WORLD?
-
7/31/2019 2012Influvac Product Presentation
3/22
Our world is one BIG FAMILY!
-
7/31/2019 2012Influvac Product Presentation
4/22
Protection from Influenza
Influenza is a highly contagious
respiratory infection brought
about by virus and its commonly
known asFLU or TRANGKASO
Ranked as the 4th leading cause of morbidity in thePhilippines after pneumonia.
-
7/31/2019 2012Influvac Product Presentation
5/22
-
7/31/2019 2012Influvac Product Presentation
6/22
3-4 days illness, followed by weeks of fatigue
and feeling under the weather
the need to take time off work
severe interference in everyday life
medical complications for those suffering from
asthma leading to pneumonia or other deadly
illnesses
INFLUENZA can lead to:
-
7/31/2019 2012Influvac Product Presentation
7/22
FLU can leave your business paralyzedand costs companies considerable money
each year because of:
Absenteeism
Presenteeism
Replacement and overtime cost
Interruption of services and delivery
Lost of productivity and sales
Increased healthcare cost
-
7/31/2019 2012Influvac Product Presentation
8/22
Spending time feeling ill with flu is a matter of choice;
Flu could lead to something more serious than
just a week feeling sick...
What kind of opportunities could we lose in a week?
So maybe flu vaccination is more of a benefit than
actually an obligation...
-
7/31/2019 2012Influvac Product Presentation
9/22
PROTECT YOUR WORLD
FLU vaccination remains the cornerstone
of preventing influenza.
The BESTway to prevent flu is toget a flu vaccination each year.
FLU vaccination doesnt protect only you,
it also prevents spreading flu to others.
-
7/31/2019 2012Influvac Product Presentation
10/22
PROTECT YOUR WORKFORCE,
PROTECT YOUR BUSINESS
significant reduction in overall mortality
hospitalisation for cardiac events
hospitalisation for stroke
physicians visit for upper respiratoryillnesses
days of sick leave from work due to upperrespiratory illnesses
work absenteeism due to illnesses
-
7/31/2019 2012Influvac Product Presentation
11/22
Protect yourself, Protect your loved ones
Chronic respiratory disease, including asthma
Chronic heart disease
Chronic renal disease
Diabetes Mellitus
Immunosuppression due to illness or treatment
Everybody aged 65 years and over, depending on local
guidelines
Groups at high risk for influenza complicationsAdult and children with any of the following risks:
Elderly:
-
7/31/2019 2012Influvac Product Presentation
12/22
The only Sub-unit Influenza Vaccine with
Dupharject advantage
-
7/31/2019 2012Influvac Product Presentation
13/22
Historical development in influenza vaccination
-
7/31/2019 2012Influvac Product Presentation
14/22
has been in the influenza vaccine market for over 60
years with uninterrupted supply
currently available in more than 75 countries
composition complies with WHO guidelines
well-established safety and tolerability profile;
no unexpected adverse events have been reported
convenient to administer with the pre-filled syringe
-
7/31/2019 2012Influvac Product Presentation
15/22
is a third-generation vaccine with a good safetyprofile and lower rate of reactogenicity than split and
whole virus vaccines1
(1) Beyer WEP, Palache AM, Osterhaus ADME. Clin Drug Invest1998;15:1-12
-
7/31/2019 2012Influvac Product Presentation
16/22
an A/California/7/2009 (H1N1)pdm09-like virus;
an A/Perth/16/2009 (H3N2)-like virus;
a B/Brisbane/60/2008-like virus.
contains the Southern Hemisphere 2012
Influenza Strain Composition Recommended by the World Health
Organization
STRAINS INCLUDED IN
THE VACCINE
World Health Organization 2012 Guidelines
-
7/31/2019 2012Influvac Product Presentation
17/22
Influvacs Dupharject System
-
7/31/2019 2012Influvac Product Presentation
18/22
is administered as a 0.5 ml dose
for children 3 years old and above,
0.25 ml dose in children (635 months of age)
Influvac is not indicated for use in children
-
7/31/2019 2012Influvac Product Presentation
19/22
EMPLOYEES EDUCATION
Patient Awareness Flyers
Flu Prevention Lecture
DURING VACCINATION
Flexible team of Doctors and
Nurses to conduct on sitevaccination
Hygienic disposal of usedmaterials
AFTER SALES Influcare monitoring card for
employees vaccinedocumentation
INFLUCARE PROGRAM
-
7/31/2019 2012Influvac Product Presentation
20/22
Advantages of INFLUVAC
SUB-UNIT VACCINE excellent safety profile, lower rate of local and
systemic reactions, ensure lower incidence of unwanted side-effects.
DUPHARJECT SYRINGE SYSTEM ensures nearly painless injection and
offers maximum comfort of administration because of the silicone
coated needle. It has a special seal that is proven to protect against
microbial contamination, both during storage and upon injection(absence of reflux, rigid needle guard)
INFLUCARE PROGRAM complete program before, during and after
vaccination.To access the cost-benefit calculator for influenza vaccination in workplace,
visit www.influtec.com.
-
7/31/2019 2012Influvac Product Presentation
21/22
PROTECT YOUR WORKFORCE,
PROTECT YOUR BUSINESS
Because every organization is one
BIG FAMILY!
Be INFLUVACcinated!
-
7/31/2019 2012Influvac Product Presentation
22/22
Thank you